Company Monitoring Page for Roche

latest headlines for company on cafepharma

ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
Xconomy
Tue, 10/1/19 - 10:29 am
Tags:
ESMO, PARP inhibitors, prostate cancer, KRAS, Seattle Genetics, AstraZeneca, Merck, GSK, Amgen, breast cancer, Roche, Pfizer
Roche gets FDA nod for Rituxan to treat children with two blood vessel disorders
Pharmaceutical Business Review
Mon, 09/30/19 - 12:09 pm
Tags:
Roche, FDA, Rituxan, eosinophilic granulomatosis with polyangiitis, microscopic polyangiitis
Roche sets new deadline for Spark acquisition as divestiture speculation brews
Endpoints
Mon, 09/30/19 - 12:00 pm
Tags:
Roche, Spark Therapeutics, M&A
ESMO: AZ, Merck's Lynparza chases Avastin combo nod with big ovarian cancer win
Fierce Pharma
Sat, 09/28/19 - 04:49 pm
Tags:
Roche, Avastin, ovarian cancer, AstraZeneca, Merck, Lynparza, ESMO
Roche-Spark deal review in U.K. unnerves M&A watchers—and they were spooked already
Fierce Pharma
Wed, 09/25/19 - 11:57 am
Tags:
M&A, UK, Spark Therapeutics, Roche, antitrust, CMA
Roche AI Program Can Predict Progression of Diabetic Retinopathy
BioSpace
Tue, 09/24/19 - 07:11 pm
Tags:
artificial intelligence, Roche, Genentech, diabetic retinopathy, deep learning
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
Sun, 09/22/19 - 11:10 pm
Tags:
JNJ, daratumumab, Urogen, Rhythm Pharmaceuticals, Anavex, Aravive Biologics, TrovaGene, Incyte, AstraZeneca, Roche, Amgen, Aslan, G1 Therapeutics, GSK, Calithera Biosciences, Seattle Genetics, Immunomedics, Checkpoint Therapeutics, Aileron Therapeutics, Genocea Biosciences, AbbVie, Zymeworks
Roche Packs New FDA-Approved Test in Its Arsenal
Medical Devices and Diagnostics Industry
Sun, 09/22/19 - 10:59 pm
Tags:
Roche, Babesia test, Babesia DNA, Babesia RNA, diagnostics
After touting Gazyva's potential in lupus, Roche nabs 'breakthrough' ahead of PhIII
Endpoints
Wed, 09/18/19 - 10:02 am
Tags:
Roche, Gazyva, lupus nephritis
Roche and Celgene set for battle in acute myelogenous leukaemia
EP Vantage
Wed, 09/18/19 - 09:54 am
Tags:
Celgene, Roche, AML, acute myeloid leukemia, CC-486, Venclexta
ECTRIMS: Roche's Ocrevus, given early, cuts wheelchair risk by 42%
Fierce Pharma
Sun, 09/15/19 - 09:59 pm
Tags:
Roche, Ocrevus, multiple sclerosis
Renal Cell Carcinoma Space in Focus: Some Key Developments
Yahoo/Zacks.com
Sat, 09/14/19 - 11:18 am
Tags:
renal cell carcinoma, kidney cancer, Exelixis, Roche, Merck, Aveo Oncology
As ‘big three’ oncology meds lose sales, Roche looks to file subcutaneous breast cancer combo
Pharmaforum
Fri, 09/13/19 - 10:56 am
Tags:
Roche, Perjeta, Herceptin, Genentech, HER2-positive breast cancer
Roche's satralizumab cuts relapse risk in rare disease phase 3
Fierce Biotech
Thu, 09/12/19 - 10:37 am
Tags:
Roche, satralizumab, neuromyelitis optica spectrum disorder
Roche’s Tecentriq monotherapy significantly improves OS in phase III lung cancer study
Pharmaceutical Business Review
Thu, 09/12/19 - 10:17 am
Tags:
Roche, Tecentriq, clinical trials, non-small cell lung cancer
FDA Approval of Roche Cancer Drug Confirms Beginning of New Oncology Era
Motley Fool
Wed, 09/11/19 - 12:46 pm
Tags:
Roche, FDA, entrectinib, cancer
Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus
EP Vantage
Tue, 09/10/19 - 11:49 pm
Tags:
ESMO, Keytruda, Tecentriq, Merck, Roche
What could help biotech close out 2019 stronger? Analysts pick 3 events to watch
Biopharma Dive
Sat, 09/7/19 - 06:38 pm
Tags:
Amgen, AMG 510, KRAS inhibitors, Roche, PTC Therapeutics, risdiplam, Eylea, Novartis
Who will be the biggest pharma players in orphan drugs?
Pharmaforum
Sat, 09/7/19 - 06:25 pm
Tags:
orphan drugs, Roche, M&A, AbbVie, JNJ
Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie
Endpoints
Fri, 09/6/19 - 10:09 am
Tags:
Roche, Europe, non-squamous cell non-small cell lung cancer, Tecentriq

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.